nodes	percent_of_prediction	percent_of_DWPC	metapath
Ursodeoxycholic acid—ABCC4—Fluorouracil—urinary bladder cancer	0.11	0.193	CbGbCtD
Ursodeoxycholic acid—ABCB11—Doxorubicin—urinary bladder cancer	0.0711	0.125	CbGbCtD
Ursodeoxycholic acid—ABCC2—Carboplatin—urinary bladder cancer	0.0653	0.114	CbGbCtD
Ursodeoxycholic acid—ABCC4—Methotrexate—urinary bladder cancer	0.0609	0.107	CbGbCtD
Ursodeoxycholic acid—ABCC2—Cisplatin—urinary bladder cancer	0.0558	0.0977	CbGbCtD
Ursodeoxycholic acid—ABCC2—Etoposide—urinary bladder cancer	0.0548	0.096	CbGbCtD
Ursodeoxycholic acid—SLCO1A2—Methotrexate—urinary bladder cancer	0.0437	0.0765	CbGbCtD
Ursodeoxycholic acid—ABCC2—Doxorubicin—urinary bladder cancer	0.0374	0.0655	CbGbCtD
Ursodeoxycholic acid—ABCC2—Methotrexate—urinary bladder cancer	0.0362	0.0634	CbGbCtD
Ursodeoxycholic acid—CYP2E1—Etoposide—urinary bladder cancer	0.0353	0.0619	CbGbCtD
Ursodeoxycholic acid—AKR1C2—prostate gland—urinary bladder cancer	0.0122	0.157	CbGeAlD
Ursodeoxycholic acid—Chenodeoxycholic acid—UGT2B7—urinary bladder cancer	0.00776	1	CrCbGaD
Ursodeoxycholic acid—NR1H4—prostate gland—urinary bladder cancer	0.00641	0.0824	CbGeAlD
Ursodeoxycholic acid—SLC10A2—renal system—urinary bladder cancer	0.00555	0.0714	CbGeAlD
Ursodeoxycholic acid—SLC10A1—prostate gland—urinary bladder cancer	0.00441	0.0567	CbGeAlD
Ursodeoxycholic acid—NR1H4—renal system—urinary bladder cancer	0.00437	0.0562	CbGeAlD
Ursodeoxycholic acid—SLC10A2—vagina—urinary bladder cancer	0.00402	0.0517	CbGeAlD
Ursodeoxycholic acid—CYP2E1—urine—urinary bladder cancer	0.0039	0.0501	CbGeAlD
Ursodeoxycholic acid—AKR1C2—lymph node—urinary bladder cancer	0.0039	0.0501	CbGeAlD
Ursodeoxycholic acid—SLC10A1—seminal vesicle—urinary bladder cancer	0.00373	0.0479	CbGeAlD
Ursodeoxycholic acid—NR1H4—female reproductive system—urinary bladder cancer	0.0035	0.045	CbGeAlD
Ursodeoxycholic acid—SLC10A1—renal system—urinary bladder cancer	0.003	0.0386	CbGeAlD
Ursodeoxycholic acid—SLC10A1—female reproductive system—urinary bladder cancer	0.00241	0.0309	CbGeAlD
Ursodeoxycholic acid—ABCC4—prostate gland—urinary bladder cancer	0.00229	0.0294	CbGeAlD
Ursodeoxycholic acid—ABCC2—prostate gland—urinary bladder cancer	0.00222	0.0285	CbGeAlD
Ursodeoxycholic acid—NR1H4—lymph node—urinary bladder cancer	0.00205	0.0263	CbGeAlD
Ursodeoxycholic acid—SLCO1A2—renal system—urinary bladder cancer	0.00162	0.0208	CbGeAlD
Ursodeoxycholic acid—ABCC4—renal system—urinary bladder cancer	0.00156	0.0201	CbGeAlD
Ursodeoxycholic acid—ABCC2—renal system—urinary bladder cancer	0.00151	0.0194	CbGeAlD
Ursodeoxycholic acid—CYP2E1—prostate gland—urinary bladder cancer	0.0014	0.018	CbGeAlD
Ursodeoxycholic acid—ABCC4—female reproductive system—urinary bladder cancer	0.00125	0.0161	CbGeAlD
Ursodeoxycholic acid—ABCC2—female reproductive system—urinary bladder cancer	0.00121	0.0156	CbGeAlD
Ursodeoxycholic acid—CYP2E1—seminal vesicle—urinary bladder cancer	0.00118	0.0152	CbGeAlD
Ursodeoxycholic acid—CYP2E1—renal system—urinary bladder cancer	0.000954	0.0123	CbGeAlD
Ursodeoxycholic acid—CYP2E1—urethra—urinary bladder cancer	0.000937	0.012	CbGeAlD
Ursodeoxycholic acid—CYP2E1—female reproductive system—urinary bladder cancer	0.000764	0.00982	CbGeAlD
Ursodeoxycholic acid—ABCC4—lymph node—urinary bladder cancer	0.000731	0.0094	CbGeAlD
Ursodeoxycholic acid—ABCC2—lymph node—urinary bladder cancer	0.000708	0.0091	CbGeAlD
Ursodeoxycholic acid—NR1H4—Generic Transcription Pathway—ESR2—urinary bladder cancer	0.000168	0.00186	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism—UGT2B7—urinary bladder cancer	0.000164	0.00181	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Metabolism—CYP4B1—urinary bladder cancer	0.000163	0.0018	CbGpPWpGaD
Ursodeoxycholic acid—AKR1C2—Metabolism—RRM2—urinary bladder cancer	0.000163	0.0018	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000162	0.00179	CbGpPWpGaD
Ursodeoxycholic acid—ABCC2—NRF2 pathway—GSTM1—urinary bladder cancer	0.00016	0.00177	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Metabolism—SLC19A1—urinary bladder cancer	0.000154	0.0017	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000153	0.00169	CbGpPWpGaD
Ursodeoxycholic acid—AKR1C2—Metabolism—ENO2—urinary bladder cancer	0.000151	0.00167	CbGpPWpGaD
Ursodeoxycholic acid—AKR1C2—Metabolism—HPGDS—urinary bladder cancer	0.000151	0.00167	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.00015	0.00166	CbGpPWpGaD
Ursodeoxycholic acid—AKR1C2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.00015	0.00166	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Metabolism—PRSS3—urinary bladder cancer	0.00015	0.00166	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism—CYP4B1—urinary bladder cancer	0.000148	0.00163	CbGpPWpGaD
Ursodeoxycholic acid—AKR1C2—Metabolism—GSTT1—urinary bladder cancer	0.000147	0.00162	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Metabolism—RRM2—urinary bladder cancer	0.000145	0.00161	CbGpPWpGaD
Ursodeoxycholic acid—AKR1C2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.000144	0.00159	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Biological oxidations—HPGDS—urinary bladder cancer	0.000142	0.00157	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism—SLC19A1—urinary bladder cancer	0.00014	0.00154	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Biological oxidations—GSTT1—urinary bladder cancer	0.000138	0.00152	CbGpPWpGaD
Ursodeoxycholic acid—ABCC2—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000137	0.00151	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism—PRSS3—urinary bladder cancer	0.000136	0.0015	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Metabolism—HPGDS—urinary bladder cancer	0.000135	0.00149	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Metabolism—ENO2—urinary bladder cancer	0.000135	0.00149	CbGpPWpGaD
Ursodeoxycholic acid—Urticaria—Etoposide—urinary bladder cancer	0.000134	0.000529	CcSEcCtD
Ursodeoxycholic acid—SLC10A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.000134	0.00148	CbGpPWpGaD
Ursodeoxycholic acid—Haemoglobin—Epirubicin—urinary bladder cancer	0.000134	0.000528	CcSEcCtD
Ursodeoxycholic acid—Jaundice—Doxorubicin—urinary bladder cancer	0.000134	0.000528	CcSEcCtD
Ursodeoxycholic acid—Rhinitis—Epirubicin—urinary bladder cancer	0.000133	0.000527	CcSEcCtD
Ursodeoxycholic acid—Abdominal pain—Etoposide—urinary bladder cancer	0.000133	0.000526	CcSEcCtD
Ursodeoxycholic acid—Body temperature increased—Etoposide—urinary bladder cancer	0.000133	0.000526	CcSEcCtD
Ursodeoxycholic acid—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000133	0.000526	CcSEcCtD
Ursodeoxycholic acid—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000133	0.000526	CcSEcCtD
Ursodeoxycholic acid—Haemorrhage—Epirubicin—urinary bladder cancer	0.000133	0.000525	CcSEcCtD
Ursodeoxycholic acid—Eye disorder—Methotrexate—urinary bladder cancer	0.000133	0.000525	CcSEcCtD
Ursodeoxycholic acid—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000133	0.000525	CcSEcCtD
Ursodeoxycholic acid—Tinnitus—Methotrexate—urinary bladder cancer	0.000132	0.000523	CcSEcCtD
Ursodeoxycholic acid—ABCC4—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000132	0.00146	CbGpPWpGaD
Ursodeoxycholic acid—Asthenia—Cisplatin—urinary bladder cancer	0.000132	0.000521	CcSEcCtD
Ursodeoxycholic acid—Pharyngitis—Epirubicin—urinary bladder cancer	0.000132	0.000521	CcSEcCtD
Ursodeoxycholic acid—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000132	0.000521	CcSEcCtD
Ursodeoxycholic acid—Sweating—Doxorubicin—urinary bladder cancer	0.000131	0.000519	CcSEcCtD
Ursodeoxycholic acid—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000131	0.000519	CcSEcCtD
Ursodeoxycholic acid—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000131	0.000517	CcSEcCtD
Ursodeoxycholic acid—Haematuria—Doxorubicin—urinary bladder cancer	0.000131	0.000516	CcSEcCtD
Ursodeoxycholic acid—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000131	0.000516	CcSEcCtD
Ursodeoxycholic acid—SLC10A2—Metabolism—GSTT1—urinary bladder cancer	0.000131	0.00144	CbGpPWpGaD
Ursodeoxycholic acid—Urethral disorder—Epirubicin—urinary bladder cancer	0.00013	0.000515	CcSEcCtD
Ursodeoxycholic acid—NR1H4—Generic Transcription Pathway—NCOR1—urinary bladder cancer	0.00013	0.00143	CbGpPWpGaD
Ursodeoxycholic acid—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.00013	0.000512	CcSEcCtD
Ursodeoxycholic acid—Epistaxis—Doxorubicin—urinary bladder cancer	0.000129	0.000511	CcSEcCtD
Ursodeoxycholic acid—Angiopathy—Methotrexate—urinary bladder cancer	0.000129	0.000509	CcSEcCtD
Ursodeoxycholic acid—SLC10A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.000129	0.00142	CbGpPWpGaD
Ursodeoxycholic acid—Sinusitis—Doxorubicin—urinary bladder cancer	0.000129	0.000508	CcSEcCtD
Ursodeoxycholic acid—NR1H4—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—urinary bladder cancer	0.000129	0.00142	CbGpPWpGaD
Ursodeoxycholic acid—Immune system disorder—Methotrexate—urinary bladder cancer	0.000128	0.000507	CcSEcCtD
Ursodeoxycholic acid—Dizziness—Fluorouracil—urinary bladder cancer	0.000128	0.000507	CcSEcCtD
Ursodeoxycholic acid—Visual impairment—Epirubicin—urinary bladder cancer	0.000128	0.000506	CcSEcCtD
Ursodeoxycholic acid—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000128	0.000506	CcSEcCtD
Ursodeoxycholic acid—Chills—Methotrexate—urinary bladder cancer	0.000127	0.000504	CcSEcCtD
Ursodeoxycholic acid—Diarrhoea—Cisplatin—urinary bladder cancer	0.000126	0.000497	CcSEcCtD
Ursodeoxycholic acid—Alopecia—Methotrexate—urinary bladder cancer	0.000126	0.000496	CcSEcCtD
Ursodeoxycholic acid—Vomiting—Gemcitabine—urinary bladder cancer	0.000125	0.000496	CcSEcCtD
Ursodeoxycholic acid—Rash—Gemcitabine—urinary bladder cancer	0.000124	0.000492	CcSEcCtD
Ursodeoxycholic acid—Dermatitis—Gemcitabine—urinary bladder cancer	0.000124	0.000491	CcSEcCtD
Ursodeoxycholic acid—Eye disorder—Epirubicin—urinary bladder cancer	0.000124	0.000491	CcSEcCtD
Ursodeoxycholic acid—Hypersensitivity—Etoposide—urinary bladder cancer	0.000124	0.000491	CcSEcCtD
Ursodeoxycholic acid—Tinnitus—Epirubicin—urinary bladder cancer	0.000124	0.00049	CcSEcCtD
Ursodeoxycholic acid—Malnutrition—Methotrexate—urinary bladder cancer	0.000124	0.000489	CcSEcCtD
Ursodeoxycholic acid—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000124	0.000489	CcSEcCtD
Ursodeoxycholic acid—Headache—Gemcitabine—urinary bladder cancer	0.000124	0.000488	CcSEcCtD
Ursodeoxycholic acid—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000123	0.000488	CcSEcCtD
Ursodeoxycholic acid—Vomiting—Fluorouracil—urinary bladder cancer	0.000123	0.000487	CcSEcCtD
Ursodeoxycholic acid—Rhinitis—Doxorubicin—urinary bladder cancer	0.000123	0.000487	CcSEcCtD
Ursodeoxycholic acid—ABCB11—Metabolism—GSTZ1—urinary bladder cancer	0.000123	0.00136	CbGpPWpGaD
Ursodeoxycholic acid—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000123	0.000486	CcSEcCtD
Ursodeoxycholic acid—SLCO1A2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000123	0.00135	CbGpPWpGaD
Ursodeoxycholic acid—Rash—Fluorouracil—urinary bladder cancer	0.000122	0.000483	CcSEcCtD
Ursodeoxycholic acid—SLC10A2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000122	0.00135	CbGpPWpGaD
Ursodeoxycholic acid—Dermatitis—Fluorouracil—urinary bladder cancer	0.000122	0.000483	CcSEcCtD
Ursodeoxycholic acid—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000122	0.000482	CcSEcCtD
Ursodeoxycholic acid—AKR1C2—Metabolism—NQO1—urinary bladder cancer	0.000122	0.00134	CbGpPWpGaD
Ursodeoxycholic acid—Headache—Fluorouracil—urinary bladder cancer	0.000122	0.00048	CcSEcCtD
Ursodeoxycholic acid—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000122	0.00048	CcSEcCtD
Ursodeoxycholic acid—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000121	0.000479	CcSEcCtD
Ursodeoxycholic acid—Asthenia—Etoposide—urinary bladder cancer	0.000121	0.000478	CcSEcCtD
Ursodeoxycholic acid—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000121	0.000478	CcSEcCtD
Ursodeoxycholic acid—Angiopathy—Epirubicin—urinary bladder cancer	0.000121	0.000477	CcSEcCtD
Ursodeoxycholic acid—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000121	0.000476	CcSEcCtD
Ursodeoxycholic acid—SLC10A1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.00012	0.00133	CbGpPWpGaD
Ursodeoxycholic acid—Immune system disorder—Epirubicin—urinary bladder cancer	0.00012	0.000474	CcSEcCtD
Ursodeoxycholic acid—SLC10A1—Metabolism—TYMP—urinary bladder cancer	0.00012	0.00132	CbGpPWpGaD
Ursodeoxycholic acid—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.00012	0.000473	CcSEcCtD
Ursodeoxycholic acid—Back pain—Methotrexate—urinary bladder cancer	0.00012	0.000473	CcSEcCtD
Ursodeoxycholic acid—Chills—Epirubicin—urinary bladder cancer	0.000119	0.000471	CcSEcCtD
Ursodeoxycholic acid—Pruritus—Etoposide—urinary bladder cancer	0.000119	0.000471	CcSEcCtD
Ursodeoxycholic acid—Arrhythmia—Epirubicin—urinary bladder cancer	0.000119	0.000469	CcSEcCtD
Ursodeoxycholic acid—Visual impairment—Doxorubicin—urinary bladder cancer	0.000119	0.000468	CcSEcCtD
Ursodeoxycholic acid—AKR1C2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	0.000118	0.0013	CbGpPWpGaD
Ursodeoxycholic acid—Alopecia—Epirubicin—urinary bladder cancer	0.000118	0.000464	CcSEcCtD
Ursodeoxycholic acid—Nausea—Gemcitabine—urinary bladder cancer	0.000117	0.000463	CcSEcCtD
Ursodeoxycholic acid—Vomiting—Cisplatin—urinary bladder cancer	0.000117	0.000462	CcSEcCtD
Ursodeoxycholic acid—ABCB11—Metabolism—GSTO2—urinary bladder cancer	0.000117	0.00129	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism—NAT1—urinary bladder cancer	0.000117	0.00129	CbGpPWpGaD
Ursodeoxycholic acid—Rash—Cisplatin—urinary bladder cancer	0.000116	0.000458	CcSEcCtD
Ursodeoxycholic acid—Dermatitis—Cisplatin—urinary bladder cancer	0.000116	0.000458	CcSEcCtD
Ursodeoxycholic acid—Malnutrition—Epirubicin—urinary bladder cancer	0.000116	0.000457	CcSEcCtD
Ursodeoxycholic acid—Diarrhoea—Etoposide—urinary bladder cancer	0.000115	0.000456	CcSEcCtD
Ursodeoxycholic acid—SLC10A1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.000115	0.00127	CbGpPWpGaD
Ursodeoxycholic acid—Nausea—Fluorouracil—urinary bladder cancer	0.000115	0.000455	CcSEcCtD
Ursodeoxycholic acid—Eye disorder—Doxorubicin—urinary bladder cancer	0.000115	0.000454	CcSEcCtD
Ursodeoxycholic acid—ABCB11—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000115	0.00127	CbGpPWpGaD
Ursodeoxycholic acid—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000115	0.000453	CcSEcCtD
Ursodeoxycholic acid—Tinnitus—Doxorubicin—urinary bladder cancer	0.000115	0.000453	CcSEcCtD
Ursodeoxycholic acid—Anaemia—Methotrexate—urinary bladder cancer	0.000114	0.000452	CcSEcCtD
Ursodeoxycholic acid—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000114	0.000451	CcSEcCtD
Ursodeoxycholic acid—Flatulence—Epirubicin—urinary bladder cancer	0.000114	0.000451	CcSEcCtD
Ursodeoxycholic acid—Tension—Epirubicin—urinary bladder cancer	0.000114	0.000449	CcSEcCtD
Ursodeoxycholic acid—Nervousness—Epirubicin—urinary bladder cancer	0.000112	0.000444	CcSEcCtD
Ursodeoxycholic acid—Back pain—Epirubicin—urinary bladder cancer	0.000112	0.000442	CcSEcCtD
Ursodeoxycholic acid—ABCC2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000112	0.00123	CbGpPWpGaD
Ursodeoxycholic acid—Angiopathy—Doxorubicin—urinary bladder cancer	0.000112	0.000441	CcSEcCtD
Ursodeoxycholic acid—Malaise—Methotrexate—urinary bladder cancer	0.000112	0.000441	CcSEcCtD
Ursodeoxycholic acid—Dizziness—Etoposide—urinary bladder cancer	0.000111	0.00044	CcSEcCtD
Ursodeoxycholic acid—Muscle spasms—Epirubicin—urinary bladder cancer	0.000111	0.00044	CcSEcCtD
Ursodeoxycholic acid—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000111	0.000439	CcSEcCtD
Ursodeoxycholic acid—Vertigo—Methotrexate—urinary bladder cancer	0.000111	0.000439	CcSEcCtD
Ursodeoxycholic acid—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000111	0.000438	CcSEcCtD
Ursodeoxycholic acid—Leukopenia—Methotrexate—urinary bladder cancer	0.000111	0.000437	CcSEcCtD
Ursodeoxycholic acid—Chills—Doxorubicin—urinary bladder cancer	0.00011	0.000436	CcSEcCtD
Ursodeoxycholic acid—Arrhythmia—Doxorubicin—urinary bladder cancer	0.00011	0.000434	CcSEcCtD
Ursodeoxycholic acid—Nausea—Cisplatin—urinary bladder cancer	0.000109	0.000432	CcSEcCtD
Ursodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.000109	0.0012	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism—TYMP—urinary bladder cancer	0.000109	0.0012	CbGpPWpGaD
Ursodeoxycholic acid—Alopecia—Doxorubicin—urinary bladder cancer	0.000109	0.00043	CcSEcCtD
Ursodeoxycholic acid—SLC10A1—Metabolism—NAT2—urinary bladder cancer	0.000109	0.0012	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Metabolism—NQO1—urinary bladder cancer	0.000109	0.0012	CbGpPWpGaD
Ursodeoxycholic acid—Cough—Methotrexate—urinary bladder cancer	0.000108	0.000426	CcSEcCtD
Ursodeoxycholic acid—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000107	0.000424	CcSEcCtD
Ursodeoxycholic acid—Convulsion—Methotrexate—urinary bladder cancer	0.000107	0.000423	CcSEcCtD
Ursodeoxycholic acid—Vomiting—Etoposide—urinary bladder cancer	0.000107	0.000423	CcSEcCtD
Ursodeoxycholic acid—Malnutrition—Doxorubicin—urinary bladder cancer	0.000107	0.000423	CcSEcCtD
Ursodeoxycholic acid—Anaemia—Epirubicin—urinary bladder cancer	0.000107	0.000423	CcSEcCtD
Ursodeoxycholic acid—ABCB11—Metabolism—UGT2B7—urinary bladder cancer	0.000107	0.00118	CbGpPWpGaD
Ursodeoxycholic acid—Rash—Etoposide—urinary bladder cancer	0.000106	0.00042	CcSEcCtD
Ursodeoxycholic acid—Dermatitis—Etoposide—urinary bladder cancer	0.000106	0.000419	CcSEcCtD
Ursodeoxycholic acid—Headache—Etoposide—urinary bladder cancer	0.000106	0.000417	CcSEcCtD
Ursodeoxycholic acid—Flatulence—Doxorubicin—urinary bladder cancer	0.000106	0.000417	CcSEcCtD
Ursodeoxycholic acid—SLC10A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	0.000105	0.00116	CbGpPWpGaD
Ursodeoxycholic acid—Myalgia—Methotrexate—urinary bladder cancer	0.000105	0.000416	CcSEcCtD
Ursodeoxycholic acid—Arthralgia—Methotrexate—urinary bladder cancer	0.000105	0.000416	CcSEcCtD
Ursodeoxycholic acid—Chest pain—Methotrexate—urinary bladder cancer	0.000105	0.000416	CcSEcCtD
Ursodeoxycholic acid—Tension—Doxorubicin—urinary bladder cancer	0.000105	0.000415	CcSEcCtD
Ursodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000105	0.000413	CcSEcCtD
Ursodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.000105	0.00115	CbGpPWpGaD
Ursodeoxycholic acid—Malaise—Epirubicin—urinary bladder cancer	0.000104	0.000412	CcSEcCtD
Ursodeoxycholic acid—Discomfort—Methotrexate—urinary bladder cancer	0.000104	0.000411	CcSEcCtD
Ursodeoxycholic acid—Nervousness—Doxorubicin—urinary bladder cancer	0.000104	0.000411	CcSEcCtD
Ursodeoxycholic acid—Vertigo—Epirubicin—urinary bladder cancer	0.000104	0.000411	CcSEcCtD
Ursodeoxycholic acid—Syncope—Epirubicin—urinary bladder cancer	0.000104	0.00041	CcSEcCtD
Ursodeoxycholic acid—Leukopenia—Epirubicin—urinary bladder cancer	0.000104	0.000409	CcSEcCtD
Ursodeoxycholic acid—Back pain—Doxorubicin—urinary bladder cancer	0.000104	0.000409	CcSEcCtD
Ursodeoxycholic acid—AKR1C2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	0.000103	0.00114	CbGpPWpGaD
Ursodeoxycholic acid—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000103	0.000407	CcSEcCtD
Ursodeoxycholic acid—SLCO1A2—Metabolism—GSTZ1—urinary bladder cancer	0.000103	0.00113	CbGpPWpGaD
Ursodeoxycholic acid—Palpitations—Epirubicin—urinary bladder cancer	0.000102	0.000404	CcSEcCtD
Ursodeoxycholic acid—NR1H4—Generic Transcription Pathway—ESR1—urinary bladder cancer	0.000102	0.00113	CbGpPWpGaD
Ursodeoxycholic acid—Confusional state—Methotrexate—urinary bladder cancer	0.000102	0.000402	CcSEcCtD
Ursodeoxycholic acid—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000102	0.000402	CcSEcCtD
Ursodeoxycholic acid—AKR1C2—Metabolism—GSTP1—urinary bladder cancer	0.000102	0.00112	CbGpPWpGaD
Ursodeoxycholic acid—Cough—Epirubicin—urinary bladder cancer	0.000101	0.000399	CcSEcCtD
Ursodeoxycholic acid—Convulsion—Epirubicin—urinary bladder cancer	0.0001	0.000396	CcSEcCtD
Ursodeoxycholic acid—Infection—Methotrexate—urinary bladder cancer	0.0001	0.000396	CcSEcCtD
Ursodeoxycholic acid—Nausea—Etoposide—urinary bladder cancer	0.0001	0.000395	CcSEcCtD
Ursodeoxycholic acid—Hypertension—Epirubicin—urinary bladder cancer	9.99e-05	0.000395	CcSEcCtD
Ursodeoxycholic acid—Ill-defined disorder—Doxorubicin—urinary bladder cancer	9.94e-05	0.000393	CcSEcCtD
Ursodeoxycholic acid—Nervous system disorder—Methotrexate—urinary bladder cancer	9.9e-05	0.000391	CcSEcCtD
Ursodeoxycholic acid—Anaemia—Doxorubicin—urinary bladder cancer	9.9e-05	0.000391	CcSEcCtD
Ursodeoxycholic acid—Thrombocytopenia—Methotrexate—urinary bladder cancer	9.88e-05	0.00039	CcSEcCtD
Ursodeoxycholic acid—Arthralgia—Epirubicin—urinary bladder cancer	9.85e-05	0.000389	CcSEcCtD
Ursodeoxycholic acid—Chest pain—Epirubicin—urinary bladder cancer	9.85e-05	0.000389	CcSEcCtD
Ursodeoxycholic acid—Myalgia—Epirubicin—urinary bladder cancer	9.85e-05	0.000389	CcSEcCtD
Ursodeoxycholic acid—NR1H4—Metabolism—NAT2—urinary bladder cancer	9.84e-05	0.00109	CbGpPWpGaD
Ursodeoxycholic acid—AKR1C2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	9.83e-05	0.00108	CbGpPWpGaD
Ursodeoxycholic acid—Skin disorder—Methotrexate—urinary bladder cancer	9.81e-05	0.000387	CcSEcCtD
Ursodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	9.79e-05	0.000387	CcSEcCtD
Ursodeoxycholic acid—Hyperhidrosis—Methotrexate—urinary bladder cancer	9.76e-05	0.000386	CcSEcCtD
Ursodeoxycholic acid—SLCO1A2—Metabolism—GSTO2—urinary bladder cancer	9.75e-05	0.00108	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism—NAT1—urinary bladder cancer	9.75e-05	0.00108	CbGpPWpGaD
Ursodeoxycholic acid—Discomfort—Epirubicin—urinary bladder cancer	9.74e-05	0.000385	CcSEcCtD
Ursodeoxycholic acid—Malaise—Doxorubicin—urinary bladder cancer	9.66e-05	0.000382	CcSEcCtD
Ursodeoxycholic acid—Dry mouth—Epirubicin—urinary bladder cancer	9.64e-05	0.000381	CcSEcCtD
Ursodeoxycholic acid—Vertigo—Doxorubicin—urinary bladder cancer	9.62e-05	0.00038	CcSEcCtD
Ursodeoxycholic acid—Anorexia—Methotrexate—urinary bladder cancer	9.62e-05	0.00038	CcSEcCtD
Ursodeoxycholic acid—ABCB11—Metabolism—CYP4B1—urinary bladder cancer	9.62e-05	0.00106	CbGpPWpGaD
Ursodeoxycholic acid—Syncope—Doxorubicin—urinary bladder cancer	9.61e-05	0.000379	CcSEcCtD
Ursodeoxycholic acid—SLCO1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	9.59e-05	0.00106	CbGpPWpGaD
Ursodeoxycholic acid—Leukopenia—Doxorubicin—urinary bladder cancer	9.59e-05	0.000379	CcSEcCtD
Ursodeoxycholic acid—CYP2E1—Biological oxidations—GSTP1—urinary bladder cancer	9.54e-05	0.00105	CbGpPWpGaD
Ursodeoxycholic acid—Confusional state—Epirubicin—urinary bladder cancer	9.53e-05	0.000376	CcSEcCtD
Ursodeoxycholic acid—Palpitations—Doxorubicin—urinary bladder cancer	9.47e-05	0.000374	CcSEcCtD
Ursodeoxycholic acid—Oedema—Epirubicin—urinary bladder cancer	9.45e-05	0.000373	CcSEcCtD
Ursodeoxycholic acid—AKR1C2—Metabolism—TYMS—urinary bladder cancer	9.44e-05	0.00104	CbGpPWpGaD
Ursodeoxycholic acid—Hypotension—Methotrexate—urinary bladder cancer	9.43e-05	0.000373	CcSEcCtD
Ursodeoxycholic acid—Loss of consciousness—Doxorubicin—urinary bladder cancer	9.41e-05	0.000372	CcSEcCtD
Ursodeoxycholic acid—CYP2E1—Metapathway biotransformation—GSTP1—urinary bladder cancer	9.41e-05	0.00104	CbGpPWpGaD
Ursodeoxycholic acid—Infection—Epirubicin—urinary bladder cancer	9.39e-05	0.000371	CcSEcCtD
Ursodeoxycholic acid—SLC10A1—Metabolism—RRM2—urinary bladder cancer	9.37e-05	0.00103	CbGpPWpGaD
Ursodeoxycholic acid—Cough—Doxorubicin—urinary bladder cancer	9.35e-05	0.000369	CcSEcCtD
Ursodeoxycholic acid—AKR1C2—Metabolism—NCOR1—urinary bladder cancer	9.33e-05	0.00103	CbGpPWpGaD
Ursodeoxycholic acid—AKR1C2—Metabolism—GSTM1—urinary bladder cancer	9.33e-05	0.00103	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Generic Transcription Pathway—PPARG—urinary bladder cancer	9.3e-05	0.00103	CbGpPWpGaD
Ursodeoxycholic acid—Shock—Epirubicin—urinary bladder cancer	9.29e-05	0.000367	CcSEcCtD
Ursodeoxycholic acid—NR1H4—Gene Expression—SMC1A—urinary bladder cancer	9.29e-05	0.00103	CbGpPWpGaD
Ursodeoxycholic acid—Convulsion—Doxorubicin—urinary bladder cancer	9.28e-05	0.000367	CcSEcCtD
Ursodeoxycholic acid—ABCC4—Platelet activation, signaling and aggregation—IGF1—urinary bladder cancer	9.27e-05	0.00102	CbGpPWpGaD
Ursodeoxycholic acid—Nervous system disorder—Epirubicin—urinary bladder cancer	9.26e-05	0.000366	CcSEcCtD
Ursodeoxycholic acid—Thrombocytopenia—Epirubicin—urinary bladder cancer	9.25e-05	0.000365	CcSEcCtD
Ursodeoxycholic acid—Hypertension—Doxorubicin—urinary bladder cancer	9.25e-05	0.000365	CcSEcCtD
Ursodeoxycholic acid—Tachycardia—Epirubicin—urinary bladder cancer	9.22e-05	0.000364	CcSEcCtD
Ursodeoxycholic acid—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	9.2e-05	0.000363	CcSEcCtD
Ursodeoxycholic acid—SLC10A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	9.18e-05	0.00101	CbGpPWpGaD
Ursodeoxycholic acid—Skin disorder—Epirubicin—urinary bladder cancer	9.18e-05	0.000363	CcSEcCtD
Ursodeoxycholic acid—Hyperhidrosis—Epirubicin—urinary bladder cancer	9.13e-05	0.000361	CcSEcCtD
Ursodeoxycholic acid—Insomnia—Methotrexate—urinary bladder cancer	9.13e-05	0.000361	CcSEcCtD
Ursodeoxycholic acid—Myalgia—Doxorubicin—urinary bladder cancer	9.12e-05	0.00036	CcSEcCtD
Ursodeoxycholic acid—Chest pain—Doxorubicin—urinary bladder cancer	9.12e-05	0.00036	CcSEcCtD
Ursodeoxycholic acid—Arthralgia—Doxorubicin—urinary bladder cancer	9.12e-05	0.00036	CcSEcCtD
Ursodeoxycholic acid—ABCB11—Metabolism—SLC19A1—urinary bladder cancer	9.08e-05	0.001	CbGpPWpGaD
Ursodeoxycholic acid—Paraesthesia—Methotrexate—urinary bladder cancer	9.06e-05	0.000358	CcSEcCtD
Ursodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	9.06e-05	0.000358	CcSEcCtD
Ursodeoxycholic acid—SLC10A2—Metabolism—GSTP1—urinary bladder cancer	9.05e-05	0.000999	CbGpPWpGaD
Ursodeoxycholic acid—Discomfort—Doxorubicin—urinary bladder cancer	9.01e-05	0.000356	CcSEcCtD
Ursodeoxycholic acid—Anorexia—Epirubicin—urinary bladder cancer	9.01e-05	0.000356	CcSEcCtD
Ursodeoxycholic acid—Dyspnoea—Methotrexate—urinary bladder cancer	9e-05	0.000356	CcSEcCtD
Ursodeoxycholic acid—Somnolence—Methotrexate—urinary bladder cancer	8.97e-05	0.000355	CcSEcCtD
Ursodeoxycholic acid—ABCC4—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	8.95e-05	0.000987	CbGpPWpGaD
Ursodeoxycholic acid—AKR1C2—Metabolism—GPX1—urinary bladder cancer	8.94e-05	0.000987	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Generic Transcription Pathway—CREBBP—urinary bladder cancer	8.94e-05	0.000987	CbGpPWpGaD
Ursodeoxycholic acid—Dry mouth—Doxorubicin—urinary bladder cancer	8.92e-05	0.000352	CcSEcCtD
Ursodeoxycholic acid—SLCO1A2—Metabolism—UGT2B7—urinary bladder cancer	8.92e-05	0.000984	CbGpPWpGaD
Ursodeoxycholic acid—Dyspepsia—Methotrexate—urinary bladder cancer	8.89e-05	0.000351	CcSEcCtD
Ursodeoxycholic acid—ABCB11—Metabolism—PRSS3—urinary bladder cancer	8.85e-05	0.000977	CbGpPWpGaD
Ursodeoxycholic acid—Hypotension—Epirubicin—urinary bladder cancer	8.83e-05	0.000349	CcSEcCtD
Ursodeoxycholic acid—Confusional state—Doxorubicin—urinary bladder cancer	8.81e-05	0.000348	CcSEcCtD
Ursodeoxycholic acid—AKR1C2—Metabolism—ERCC2—urinary bladder cancer	8.78e-05	0.000969	CbGpPWpGaD
Ursodeoxycholic acid—Decreased appetite—Methotrexate—urinary bladder cancer	8.78e-05	0.000347	CcSEcCtD
Ursodeoxycholic acid—CYP2E1—Biological oxidations—GSTM1—urinary bladder cancer	8.77e-05	0.000968	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	8.76e-05	0.000967	CbGpPWpGaD
Ursodeoxycholic acid—Oedema—Doxorubicin—urinary bladder cancer	8.74e-05	0.000345	CcSEcCtD
Ursodeoxycholic acid—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	8.72e-05	0.000344	CcSEcCtD
Ursodeoxycholic acid—Fatigue—Methotrexate—urinary bladder cancer	8.7e-05	0.000344	CcSEcCtD
Ursodeoxycholic acid—Infection—Doxorubicin—urinary bladder cancer	8.68e-05	0.000343	CcSEcCtD
Ursodeoxycholic acid—SLC10A1—Metabolism—HPGDS—urinary bladder cancer	8.68e-05	0.000958	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Metabolism—ENO2—urinary bladder cancer	8.68e-05	0.000958	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metapathway biotransformation—GSTM1—urinary bladder cancer	8.65e-05	0.000955	CbGpPWpGaD
Ursodeoxycholic acid—Pain—Methotrexate—urinary bladder cancer	8.63e-05	0.000341	CcSEcCtD
Ursodeoxycholic acid—SLC10A1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	8.63e-05	0.000952	CbGpPWpGaD
Ursodeoxycholic acid—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	8.61e-05	0.00034	CcSEcCtD
Ursodeoxycholic acid—Shock—Doxorubicin—urinary bladder cancer	8.6e-05	0.00034	CcSEcCtD
Ursodeoxycholic acid—Nervous system disorder—Doxorubicin—urinary bladder cancer	8.57e-05	0.000339	CcSEcCtD
Ursodeoxycholic acid—Thrombocytopenia—Doxorubicin—urinary bladder cancer	8.56e-05	0.000338	CcSEcCtD
Ursodeoxycholic acid—Insomnia—Epirubicin—urinary bladder cancer	8.54e-05	0.000338	CcSEcCtD
Ursodeoxycholic acid—Tachycardia—Doxorubicin—urinary bladder cancer	8.53e-05	0.000337	CcSEcCtD
Ursodeoxycholic acid—NR1H4—Metabolism—RRM2—urinary bladder cancer	8.5e-05	0.000938	CbGpPWpGaD
Ursodeoxycholic acid—Skin disorder—Doxorubicin—urinary bladder cancer	8.49e-05	0.000335	CcSEcCtD
Ursodeoxycholic acid—ABCC4—Platelet activation, signaling and aggregation—RHOA—urinary bladder cancer	8.49e-05	0.000937	CbGpPWpGaD
Ursodeoxycholic acid—Paraesthesia—Epirubicin—urinary bladder cancer	8.48e-05	0.000335	CcSEcCtD
Ursodeoxycholic acid—Hyperhidrosis—Doxorubicin—urinary bladder cancer	8.45e-05	0.000334	CcSEcCtD
Ursodeoxycholic acid—Dyspnoea—Epirubicin—urinary bladder cancer	8.42e-05	0.000333	CcSEcCtD
Ursodeoxycholic acid—SLC10A1—Metabolism—GSTT1—urinary bladder cancer	8.42e-05	0.000929	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Metabolism—TYMS—urinary bladder cancer	8.42e-05	0.000929	CbGpPWpGaD
Ursodeoxycholic acid—Somnolence—Epirubicin—urinary bladder cancer	8.4e-05	0.000332	CcSEcCtD
Ursodeoxycholic acid—Anorexia—Doxorubicin—urinary bladder cancer	8.33e-05	0.000329	CcSEcCtD
Ursodeoxycholic acid—SLC10A2—Metabolism—NCOR1—urinary bladder cancer	8.32e-05	0.000918	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Metabolism—GSTM1—urinary bladder cancer	8.32e-05	0.000918	CbGpPWpGaD
Ursodeoxycholic acid—Feeling abnormal—Methotrexate—urinary bladder cancer	8.32e-05	0.000329	CcSEcCtD
Ursodeoxycholic acid—Dyspepsia—Epirubicin—urinary bladder cancer	8.32e-05	0.000329	CcSEcCtD
Ursodeoxycholic acid—SLC10A1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	8.29e-05	0.000915	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	8.29e-05	0.000915	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Hemostasis—IFNA2—urinary bladder cancer	8.26e-05	0.000912	CbGpPWpGaD
Ursodeoxycholic acid—Gastrointestinal pain—Methotrexate—urinary bladder cancer	8.25e-05	0.000326	CcSEcCtD
Ursodeoxycholic acid—AKR1C2—Metabolism—MTHFR—urinary bladder cancer	8.25e-05	0.000911	CbGpPWpGaD
Ursodeoxycholic acid—Decreased appetite—Epirubicin—urinary bladder cancer	8.21e-05	0.000324	CcSEcCtD
Ursodeoxycholic acid—Hypotension—Doxorubicin—urinary bladder cancer	8.17e-05	0.000323	CcSEcCtD
Ursodeoxycholic acid—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	8.16e-05	0.000322	CcSEcCtD
Ursodeoxycholic acid—Fatigue—Epirubicin—urinary bladder cancer	8.14e-05	0.000322	CcSEcCtD
Ursodeoxycholic acid—ABCC4—Ectoderm Differentiation—MYC—urinary bladder cancer	8.12e-05	0.000896	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Gene Expression—ESR2—urinary bladder cancer	8.1e-05	0.000894	CbGpPWpGaD
Ursodeoxycholic acid—Constipation—Epirubicin—urinary bladder cancer	8.08e-05	0.000319	CcSEcCtD
Ursodeoxycholic acid—Pain—Epirubicin—urinary bladder cancer	8.08e-05	0.000319	CcSEcCtD
Ursodeoxycholic acid—SLCO1A2—Metabolism—CYP4B1—urinary bladder cancer	8.03e-05	0.000886	CbGpPWpGaD
Ursodeoxycholic acid—Urticaria—Methotrexate—urinary bladder cancer	8.02e-05	0.000317	CcSEcCtD
Ursodeoxycholic acid—Body temperature increased—Methotrexate—urinary bladder cancer	7.98e-05	0.000315	CcSEcCtD
Ursodeoxycholic acid—Abdominal pain—Methotrexate—urinary bladder cancer	7.98e-05	0.000315	CcSEcCtD
Ursodeoxycholic acid—SLC10A2—Metabolism—GPX1—urinary bladder cancer	7.97e-05	0.000879	CbGpPWpGaD
Ursodeoxycholic acid—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	7.96e-05	0.000315	CcSEcCtD
Ursodeoxycholic acid—Insomnia—Doxorubicin—urinary bladder cancer	7.91e-05	0.000312	CcSEcCtD
Ursodeoxycholic acid—NR1H4—Metabolism—ENO2—urinary bladder cancer	7.87e-05	0.000868	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism—HPGDS—urinary bladder cancer	7.87e-05	0.000868	CbGpPWpGaD
Ursodeoxycholic acid—Paraesthesia—Doxorubicin—urinary bladder cancer	7.85e-05	0.00031	CcSEcCtD
Ursodeoxycholic acid—SLC10A2—Metabolism—ERCC2—urinary bladder cancer	7.82e-05	0.000863	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	7.82e-05	0.000863	CbGpPWpGaD
Ursodeoxycholic acid—Dyspnoea—Doxorubicin—urinary bladder cancer	7.79e-05	0.000308	CcSEcCtD
Ursodeoxycholic acid—Feeling abnormal—Epirubicin—urinary bladder cancer	7.79e-05	0.000308	CcSEcCtD
Ursodeoxycholic acid—Somnolence—Doxorubicin—urinary bladder cancer	7.77e-05	0.000307	CcSEcCtD
Ursodeoxycholic acid—Gastrointestinal pain—Epirubicin—urinary bladder cancer	7.73e-05	0.000305	CcSEcCtD
Ursodeoxycholic acid—Dyspepsia—Doxorubicin—urinary bladder cancer	7.69e-05	0.000304	CcSEcCtD
Ursodeoxycholic acid—NR1H4—Metabolism—GSTT1—urinary bladder cancer	7.63e-05	0.000842	CbGpPWpGaD
Ursodeoxycholic acid—Decreased appetite—Doxorubicin—urinary bladder cancer	7.6e-05	0.0003	CcSEcCtD
Ursodeoxycholic acid—SLCO1A2—Metabolism—SLC19A1—urinary bladder cancer	7.58e-05	0.000837	CbGpPWpGaD
Ursodeoxycholic acid—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	7.55e-05	0.000298	CcSEcCtD
Ursodeoxycholic acid—ABCC2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	7.54e-05	0.000833	CbGpPWpGaD
Ursodeoxycholic acid—Fatigue—Doxorubicin—urinary bladder cancer	7.54e-05	0.000298	CcSEcCtD
Ursodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	7.51e-05	0.000829	CbGpPWpGaD
Ursodeoxycholic acid—Urticaria—Epirubicin—urinary bladder cancer	7.51e-05	0.000296	CcSEcCtD
Ursodeoxycholic acid—Pain—Doxorubicin—urinary bladder cancer	7.48e-05	0.000295	CcSEcCtD
Ursodeoxycholic acid—Constipation—Doxorubicin—urinary bladder cancer	7.48e-05	0.000295	CcSEcCtD
Ursodeoxycholic acid—Abdominal pain—Epirubicin—urinary bladder cancer	7.47e-05	0.000295	CcSEcCtD
Ursodeoxycholic acid—Body temperature increased—Epirubicin—urinary bladder cancer	7.47e-05	0.000295	CcSEcCtD
Ursodeoxycholic acid—Hypersensitivity—Methotrexate—urinary bladder cancer	7.44e-05	0.000294	CcSEcCtD
Ursodeoxycholic acid—SLCO1A2—Metabolism—PRSS3—urinary bladder cancer	7.39e-05	0.000815	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Metabolism—MTHFR—urinary bladder cancer	7.35e-05	0.000812	CbGpPWpGaD
Ursodeoxycholic acid—Asthenia—Methotrexate—urinary bladder cancer	7.24e-05	0.000286	CcSEcCtD
Ursodeoxycholic acid—Feeling abnormal—Doxorubicin—urinary bladder cancer	7.2e-05	0.000285	CcSEcCtD
Ursodeoxycholic acid—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	7.15e-05	0.000282	CcSEcCtD
Ursodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	7.14e-05	0.000789	CbGpPWpGaD
Ursodeoxycholic acid—Pruritus—Methotrexate—urinary bladder cancer	7.14e-05	0.000282	CcSEcCtD
Ursodeoxycholic acid—ABCC4—Platelet activation, signaling and aggregation—IL2—urinary bladder cancer	7.12e-05	0.000786	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	7.1e-05	0.000783	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism—TYMP—urinary bladder cancer	7.07e-05	0.000781	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Metabolism—NQO1—urinary bladder cancer	6.99e-05	0.000772	CbGpPWpGaD
Ursodeoxycholic acid—Hypersensitivity—Epirubicin—urinary bladder cancer	6.96e-05	0.000275	CcSEcCtD
Ursodeoxycholic acid—Urticaria—Doxorubicin—urinary bladder cancer	6.94e-05	0.000274	CcSEcCtD
Ursodeoxycholic acid—Body temperature increased—Doxorubicin—urinary bladder cancer	6.91e-05	0.000273	CcSEcCtD
Ursodeoxycholic acid—Abdominal pain—Doxorubicin—urinary bladder cancer	6.91e-05	0.000273	CcSEcCtD
Ursodeoxycholic acid—Diarrhoea—Methotrexate—urinary bladder cancer	6.91e-05	0.000273	CcSEcCtD
Ursodeoxycholic acid—ABCB11—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	6.79e-05	0.00075	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	6.79e-05	0.000749	CbGpPWpGaD
Ursodeoxycholic acid—Asthenia—Epirubicin—urinary bladder cancer	6.78e-05	0.000268	CcSEcCtD
Ursodeoxycholic acid—AKR1C2—Metabolism—PPARG—urinary bladder cancer	6.69e-05	0.000738	CbGpPWpGaD
Ursodeoxycholic acid—Pruritus—Epirubicin—urinary bladder cancer	6.68e-05	0.000264	CcSEcCtD
Ursodeoxycholic acid—Dizziness—Methotrexate—urinary bladder cancer	6.68e-05	0.000264	CcSEcCtD
Ursodeoxycholic acid—Diarrhoea—Epirubicin—urinary bladder cancer	6.46e-05	0.000255	CcSEcCtD
Ursodeoxycholic acid—Hypersensitivity—Doxorubicin—urinary bladder cancer	6.44e-05	0.000254	CcSEcCtD
Ursodeoxycholic acid—AKR1C2—Metabolism—CREBBP—urinary bladder cancer	6.43e-05	0.000709	CbGpPWpGaD
Ursodeoxycholic acid—Vomiting—Methotrexate—urinary bladder cancer	6.42e-05	0.000254	CcSEcCtD
Ursodeoxycholic acid—ABCB11—Metabolism—NAT2—urinary bladder cancer	6.4e-05	0.000706	CbGpPWpGaD
Ursodeoxycholic acid—Rash—Methotrexate—urinary bladder cancer	6.37e-05	0.000251	CcSEcCtD
Ursodeoxycholic acid—Dermatitis—Methotrexate—urinary bladder cancer	6.36e-05	0.000251	CcSEcCtD
Ursodeoxycholic acid—NR1H4—Metabolism—NQO1—urinary bladder cancer	6.34e-05	0.0007	CbGpPWpGaD
Ursodeoxycholic acid—Headache—Methotrexate—urinary bladder cancer	6.32e-05	0.00025	CcSEcCtD
Ursodeoxycholic acid—Asthenia—Doxorubicin—urinary bladder cancer	6.27e-05	0.000248	CcSEcCtD
Ursodeoxycholic acid—NR1H4—Gene Expression—NCOR1—urinary bladder cancer	6.25e-05	0.00069	CbGpPWpGaD
Ursodeoxycholic acid—Dizziness—Epirubicin—urinary bladder cancer	6.25e-05	0.000247	CcSEcCtD
Ursodeoxycholic acid—ABCC4—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	6.21e-05	0.000686	CbGpPWpGaD
Ursodeoxycholic acid—Pruritus—Doxorubicin—urinary bladder cancer	6.18e-05	0.000244	CcSEcCtD
Ursodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	6.15e-05	0.000679	CbGpPWpGaD
Ursodeoxycholic acid—Vomiting—Epirubicin—urinary bladder cancer	6.01e-05	0.000237	CcSEcCtD
Ursodeoxycholic acid—Nausea—Methotrexate—urinary bladder cancer	6e-05	0.000237	CcSEcCtD
Ursodeoxycholic acid—Diarrhoea—Doxorubicin—urinary bladder cancer	5.98e-05	0.000236	CcSEcCtD
Ursodeoxycholic acid—SLC10A2—Metabolism—PPARG—urinary bladder cancer	5.96e-05	0.000658	CbGpPWpGaD
Ursodeoxycholic acid—Rash—Epirubicin—urinary bladder cancer	5.96e-05	0.000235	CcSEcCtD
Ursodeoxycholic acid—Dermatitis—Epirubicin—urinary bladder cancer	5.95e-05	0.000235	CcSEcCtD
Ursodeoxycholic acid—SLCO1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	5.92e-05	0.000654	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	5.92e-05	0.000653	CbGpPWpGaD
Ursodeoxycholic acid—Headache—Epirubicin—urinary bladder cancer	5.92e-05	0.000234	CcSEcCtD
Ursodeoxycholic acid—SLCO1A2—Metabolism—TYMP—urinary bladder cancer	5.91e-05	0.000652	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Gene Expression—ERCC2—urinary bladder cancer	5.88e-05	0.000649	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Hemostasis—PLAU—urinary bladder cancer	5.86e-05	0.000647	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—GSTZ1—urinary bladder cancer	5.85e-05	0.000645	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Metabolism—GSTP1—urinary bladder cancer	5.83e-05	0.000644	CbGpPWpGaD
Ursodeoxycholic acid—Dizziness—Doxorubicin—urinary bladder cancer	5.78e-05	0.000228	CcSEcCtD
Ursodeoxycholic acid—SLC10A2—Metabolism—CREBBP—urinary bladder cancer	5.73e-05	0.000632	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	5.67e-05	0.000626	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	5.64e-05	0.000623	CbGpPWpGaD
Ursodeoxycholic acid—Nausea—Epirubicin—urinary bladder cancer	5.61e-05	0.000222	CcSEcCtD
Ursodeoxycholic acid—Vomiting—Doxorubicin—urinary bladder cancer	5.56e-05	0.00022	CcSEcCtD
Ursodeoxycholic acid—CYP2E1—Metabolism—GSTO2—urinary bladder cancer	5.54e-05	0.000612	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—NAT1—urinary bladder cancer	5.54e-05	0.000612	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism—RRM2—urinary bladder cancer	5.52e-05	0.00061	CbGpPWpGaD
Ursodeoxycholic acid—Rash—Doxorubicin—urinary bladder cancer	5.51e-05	0.000218	CcSEcCtD
Ursodeoxycholic acid—Dermatitis—Doxorubicin—urinary bladder cancer	5.51e-05	0.000218	CcSEcCtD
Ursodeoxycholic acid—Headache—Doxorubicin—urinary bladder cancer	5.48e-05	0.000216	CcSEcCtD
Ursodeoxycholic acid—SLC10A1—Metabolism—TYMS—urinary bladder cancer	5.42e-05	0.000599	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	5.37e-05	0.000592	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Metabolism—GSTM1—urinary bladder cancer	5.36e-05	0.000592	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Metabolism—NCOR1—urinary bladder cancer	5.36e-05	0.000592	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism—NAT2—urinary bladder cancer	5.34e-05	0.00059	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Generic Transcription Pathway—MYC—urinary bladder cancer	5.3e-05	0.000586	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism—GSTP1—urinary bladder cancer	5.29e-05	0.000584	CbGpPWpGaD
Ursodeoxycholic acid—AKR1C2—Metabolism—PTGS2—urinary bladder cancer	5.26e-05	0.000581	CbGpPWpGaD
Ursodeoxycholic acid—Nausea—Doxorubicin—urinary bladder cancer	5.19e-05	0.000205	CcSEcCtD
Ursodeoxycholic acid—SLC10A1—Metabolism—GPX1—urinary bladder cancer	5.13e-05	0.000567	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	5.12e-05	0.000565	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism—ENO2—urinary bladder cancer	5.11e-05	0.000565	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism—HPGDS—urinary bladder cancer	5.11e-05	0.000565	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	5.08e-05	0.000561	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—UGT2B7—urinary bladder cancer	5.07e-05	0.000559	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Metabolism—ERCC2—urinary bladder cancer	5.04e-05	0.000556	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism—GSTT1—urinary bladder cancer	4.96e-05	0.000548	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism—TYMS—urinary bladder cancer	4.92e-05	0.000543	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Gene Expression—ESR1—urinary bladder cancer	4.91e-05	0.000542	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	4.88e-05	0.000539	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism—NCOR1—urinary bladder cancer	4.86e-05	0.000536	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism—GSTM1—urinary bladder cancer	4.86e-05	0.000536	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Hemostasis—CREBBP—urinary bladder cancer	4.84e-05	0.000534	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Hemostasis—IGF1—urinary bladder cancer	4.78e-05	0.000527	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Metabolism—MTHFR—urinary bladder cancer	4.74e-05	0.000523	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Metabolism—PTGS2—urinary bladder cancer	4.69e-05	0.000518	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism—GPX1—urinary bladder cancer	4.65e-05	0.000514	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism—RRM2—urinary bladder cancer	4.61e-05	0.000509	CbGpPWpGaD
Ursodeoxycholic acid—AKR1C2—Metabolism—PTEN—urinary bladder cancer	4.59e-05	0.000507	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism—ERCC2—urinary bladder cancer	4.57e-05	0.000504	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—CYP4B1—urinary bladder cancer	4.56e-05	0.000504	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Gene Expression—PPARG—urinary bladder cancer	4.48e-05	0.000494	CbGpPWpGaD
Ursodeoxycholic acid—AKR1C2—Metabolism—EP300—urinary bladder cancer	4.38e-05	0.000483	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Hemostasis—RHOA—urinary bladder cancer	4.38e-05	0.000483	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—SLC19A1—urinary bladder cancer	4.31e-05	0.000476	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Gene Expression—CREBBP—urinary bladder cancer	4.3e-05	0.000475	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism—MTHFR—urinary bladder cancer	4.3e-05	0.000474	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism—HPGDS—urinary bladder cancer	4.27e-05	0.000471	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism—ENO2—urinary bladder cancer	4.27e-05	0.000471	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.24e-05	0.000469	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—PRSS3—urinary bladder cancer	4.2e-05	0.000464	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.19e-05	0.000462	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism—GSTT1—urinary bladder cancer	4.14e-05	0.000457	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism—NQO1—urinary bladder cancer	4.12e-05	0.000455	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Metabolism—PTEN—urinary bladder cancer	4.09e-05	0.000452	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	4.08e-05	0.00045	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	4e-05	0.000442	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Metabolism—EP300—urinary bladder cancer	3.9e-05	0.000431	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.88e-05	0.000428	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Metabolism—PPARG—urinary bladder cancer	3.84e-05	0.000424	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Metabolism—CREBBP—urinary bladder cancer	3.69e-05	0.000407	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Hemostasis—IL2—urinary bladder cancer	3.67e-05	0.000405	CbGpPWpGaD
Ursodeoxycholic acid—ABCC2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.53e-05	0.00039	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.49e-05	0.000385	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism—PPARG—urinary bladder cancer	3.48e-05	0.000384	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism—NQO1—urinary bladder cancer	3.44e-05	0.00038	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism—GSTP1—urinary bladder cancer	3.44e-05	0.00038	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—TYMP—urinary bladder cancer	3.36e-05	0.000371	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism—CREBBP—urinary bladder cancer	3.35e-05	0.000369	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.34e-05	0.000369	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.33e-05	0.000367	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Hemostasis—EP300—urinary bladder cancer	3.29e-05	0.000364	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Hemostasis—SRC—urinary bladder cancer	3.2e-05	0.000354	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism—TYMS—urinary bladder cancer	3.2e-05	0.000353	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism—GSTM1—urinary bladder cancer	3.16e-05	0.000349	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism—NCOR1—urinary bladder cancer	3.16e-05	0.000349	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—NAT2—urinary bladder cancer	3.04e-05	0.000335	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism—GPX1—urinary bladder cancer	3.03e-05	0.000334	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Metabolism—PTGS2—urinary bladder cancer	3.02e-05	0.000334	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism—ERCC2—urinary bladder cancer	2.97e-05	0.000328	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.91e-05	0.000321	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism—GSTP1—urinary bladder cancer	2.87e-05	0.000317	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism—MTHFR—urinary bladder cancer	2.79e-05	0.000308	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.78e-05	0.000307	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism—PTGS2—urinary bladder cancer	2.74e-05	0.000302	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism—TYMS—urinary bladder cancer	2.67e-05	0.000295	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Hemostasis—KRAS—urinary bladder cancer	2.65e-05	0.000293	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism—NCOR1—urinary bladder cancer	2.64e-05	0.000291	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism—GSTM1—urinary bladder cancer	2.64e-05	0.000291	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Metabolism—PTEN—urinary bladder cancer	2.64e-05	0.000291	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—RRM2—urinary bladder cancer	2.62e-05	0.000289	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Gene Expression—MYC—urinary bladder cancer	2.55e-05	0.000282	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism—GPX1—urinary bladder cancer	2.53e-05	0.000279	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Metabolism—EP300—urinary bladder cancer	2.51e-05	0.000277	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism—ERCC2—urinary bladder cancer	2.48e-05	0.000274	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—ENO2—urinary bladder cancer	2.43e-05	0.000268	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—HPGDS—urinary bladder cancer	2.43e-05	0.000268	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism—PTEN—urinary bladder cancer	2.39e-05	0.000264	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Hemostasis—TP53—urinary bladder cancer	2.36e-05	0.00026	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—GSTT1—urinary bladder cancer	2.35e-05	0.00026	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism—MTHFR—urinary bladder cancer	2.33e-05	0.000257	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism—EP300—urinary bladder cancer	2.28e-05	0.000252	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism—PPARG—urinary bladder cancer	2.26e-05	0.00025	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Hemostasis—HRAS—urinary bladder cancer	2.25e-05	0.000249	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism—CREBBP—urinary bladder cancer	2.18e-05	0.00024	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—NQO1—urinary bladder cancer	1.96e-05	0.000216	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism—PPARG—urinary bladder cancer	1.89e-05	0.000209	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism—CREBBP—urinary bladder cancer	1.82e-05	0.0002	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism—PTGS2—urinary bladder cancer	1.78e-05	0.000197	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—GSTP1—urinary bladder cancer	1.63e-05	0.00018	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism—PTEN—urinary bladder cancer	1.55e-05	0.000171	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—TYMS—urinary bladder cancer	1.52e-05	0.000167	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—NCOR1—urinary bladder cancer	1.5e-05	0.000166	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—GSTM1—urinary bladder cancer	1.5e-05	0.000166	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism—PTGS2—urinary bladder cancer	1.49e-05	0.000164	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism—EP300—urinary bladder cancer	1.48e-05	0.000164	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—GPX1—urinary bladder cancer	1.44e-05	0.000159	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—ERCC2—urinary bladder cancer	1.41e-05	0.000156	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—MTHFR—urinary bladder cancer	1.33e-05	0.000146	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism—PTEN—urinary bladder cancer	1.3e-05	0.000143	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism—EP300—urinary bladder cancer	1.24e-05	0.000137	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—PPARG—urinary bladder cancer	1.07e-05	0.000119	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—CREBBP—urinary bladder cancer	1.03e-05	0.000114	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—PTGS2—urinary bladder cancer	8.45e-06	9.33e-05	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—PTEN—urinary bladder cancer	7.37e-06	8.14e-05	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—EP300—urinary bladder cancer	7.03e-06	7.76e-05	CbGpPWpGaD
